<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03817060</url>
  </required_header>
  <id_info>
    <org_study_id>SRB_201807_150</org_study_id>
    <nct_id>NCT03817060</nct_id>
  </id_info>
  <brief_title>CuMulativE Live bIrth Rate of Patients at High Risk of OHSS After Freeze-all Embryos at Cleavage or blAstocyst Stage</brief_title>
  <acronym>MELISSA</acronym>
  <official_title>CuMulativE Live bIrth Rate of Patients at High Risk of OHSS After Freeze-all Embryos at Cleavage or blAstocyst Stage in a Single Embryo Transfer Setting (MELISSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université Libre de Bruxelles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université Libre de Bruxelles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ovarian stimulation for the induction of multifollicular growth by gonadotrophins represents
      an important part of In Vitro Fertilization (IVF). However, the use of these drugs can be
      associated with side effects, from which the most common is the Ovarian Hyperstimulation
      Syndrome (OHSS). Stimulation with gonadotrophins in a Gonadotropin-releasing hormone (GnRH)
      antagonist cycle rather than a GnRH agonist cycle reduces significantly the risk of OHSS.
      During stimulation, the best predictor of severe OHSS is the number of follicles &gt;10mm on the
      day of triggering final oocyte maturation, with the threshold at ≥16 follicles. When this
      occurs, final oocyte maturation can be induced with a GnRH agonist, reducing further the risk
      the syndrome. To perform a fresh embryo transfer, 1500 IU human Chorionic Gonadotropin (hCG)
      can be administered on the day of oocyte retrieval for the luteal support. However, with this
      procedure there are still some cases of OHSS. To overcome this, it is suggested to combine
      GnRH agonist triggering with a freeze-all embryos strategy and perform embryo replacement in
      subsequent frozen-thawed embryo transfer (FET) cycles. Different cryopreservation strategies
      are been performed according to the procedure of each fertility center, such as
      cryopreservation at 2 pronuclear (2PN), cleavage or blastocyst stage. The aim of this study
      is to determine the optimal strategy for the freeze-all cycles and particularly the optimal
      day for freezing, thawing and transferring the embryos. The hypothesis is that there will
      increased cumulative live birth rates per started cycle in blastocyst compared to cleavage
      stage FET cycles.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2019</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative live birth</measure>
    <time_frame>within one year of randomisation</time_frame>
    <description>Cumulative live birth rate per oocyte retrieval</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frozen thawed embryo transfer cycles needed to achieve live birth</measure>
    <time_frame>within one year of randomisation</time_frame>
    <description>Number of frozen thawed embryo transfer cycles needed to achieve live birth</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Cleavage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Embryos cryopreserved with vitrification at the cleavage stage (day 3) of embryo development</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blastocyst</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Embryos cryopreserved with vitrification at the blastocyst stage (day 5 or 6)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cryopreservation of embryos at cleavage stage</intervention_name>
    <description>cryopreservation of embryos at cleavage stage (day 3) of embryo development</description>
    <arm_group_label>Cleavage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cryopreservation of embryos at blastocyst stage</intervention_name>
    <description>cryopreservation of embryos at blastocyst stage (day 5 or 6) of embryo development</description>
    <arm_group_label>Blastocyst</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &lt;40 years old

          -  Indication for In Vitro Fertilisation (IVF)/Intracytoplasmic sperm injection (ICSI)

          -  No more than 2 previous failed IVF/ICSI cycles

          -  Stimulation in GnRH antagonist cycle

          -  Presence of ≥16 follicles of &gt;10mm on the day of triggering of final oocyte maturation

          -  GnRH agonist trigger (triptorelin 0.2mg)

        Exclusion Criteria:

          -  Cycles with testicular sperm extraction

          -  Preimplantation genetic diagnosis

          -  Patients with uterine malformations

          -  Patients with infectious diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Theoni Tarlatzi</last_name>
    <phone>+3225558948</phone>
    <email>nonika.tarlatzi@gmail.com</email>
  </overall_contact>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>December 7, 2018</study_first_submitted>
  <study_first_submitted_qc>January 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2019</study_first_posted>
  <last_update_submitted>January 23, 2019</last_update_submitted>
  <last_update_submitted_qc>January 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université Libre de Bruxelles</investigator_affiliation>
    <investigator_full_name>Theoni Tarlatzi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>OHSS</keyword>
  <keyword>Agonist trigger</keyword>
  <keyword>freeze-all</keyword>
  <keyword>blastocyst</keyword>
  <keyword>cleavage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

